News
NUVB
4.720
-1.26%
-0.060
Nuvation Bio Collaborates With Thermo Fisher Scientific For Lung Cancer Treatment
Dow Jones · 1d ago
Nuvation Bio collaborating with Thermo Fisher to manufacture Ibtrozi in NSCLC
TipRanks · 1d ago
Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer
PR Newswire · 1d ago
Weekly Report: what happened at NUVB last week (0504-0508)?
Weekly Report · 3d ago
A Look At Nuvation Bio (NUVB) Valuation After Profit Shift And Taletrectinib FDA And Guideline Milestones
Simply Wall St · 3d ago
Nuvation Bio Signals Durable Momentum in Earnings Call
TipRanks · 4d ago
Why Nuvation Bio (NUVB) Is Up 8.1% After FDA Accepts IBTROZI Label Update, Strong Q1 Results
Simply Wall St · 4d ago
Results: Nuvation Bio Inc. Confounded Analyst Expectations With A Surprise Profit
Simply Wall St · 6d ago
Nuvation Bio: FDA accepts sNDA with updated data for IBTROZI
TipRanks · 05/07 06:20
Nuvation bid to expand Ibtrozi label undergoes FDA review
Seeking Alpha · 05/06 15:55
Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in Advanced ROS1-Positive Non-Small Cell Lung Cancer
PR Newswire · 05/06 12:00
Nuvation Bio to Participate in Upcoming Investor Conferences
PR Newswire · 05/05 20:05
Nuvation Bio Price Target Maintained With a $20.00/Share by RBC Capital
Dow Jones · 05/05 15:45
RBC Capital Reiterates Outperform on Nuvation Bio, Maintains $20 Price Target
Benzinga · 05/05 15:36
Wedbush Keeps Their Buy Rating on Nuvation Bio (NUVB)
TipRanks · 05/05 13:47
Nuvation Bio Price Target Maintained With a $11.00/Share by Wedbush
Dow Jones · 05/05 13:47
Wedbush Reiterates Outperform on Nuvation Bio, Maintains $11 Price Target
Benzinga · 05/05 13:38
Analysts Conflicted on These Healthcare Names: Fortrea Holdings Inc. (FTRE), Vertex Pharmaceuticals (VRTX) and Nuvation Bio (NUVB)
TipRanks · 05/05 12:10
Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Evolus (EOLS)
TipRanks · 05/05 11:51
Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT), Evolus (EOLS) and Nuvation Bio (NUVB)
TipRanks · 05/05 11:21
More
Webull provides a variety of real-time NUVB stock news. You can receive the latest news about Nuvation Bio Inc through multiple platforms. This information may help you make smarter investment decisions.
About NUVB
Nuvation Bio Inc. is a global biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. Its programs include taletrectinib (ROS1 inhibitor), safusidenib (mIDH1 inhibitor), NUV-1511 (drug-drug conjugate), and NUV-868 (BET inhibitor). The Company's Taletrectinib is an oral, potent, central nervous system-active, selective, ROS1 inhibitor specifically designed for the treatment of patients with ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC). Safusidenib is a novel, oral, potent, brain penetrant, targeted inhibitor of mutant isocitrate dehydrogenase 1(mIDH1). NUV-1511, a clinical-stage drug-drug conjugate (DDC), fuses a targeting agent to a widely used chemotherapy agent. Its NUV-868 is a BD2-selective, oral, small molecule bromodomain and extra-terminal (BET) inhibitor that inhibits BRD4.